Skip to main content
Fangzhou Inc. logo

Fangzhou Inc. — Investor Relations & Filings

Ticker · 6086 ISIN · KYG3314S1066 LEI · 254900EFB6KUQZPPCC72 HKEX Human health and social work activities
Open in API
Filings indexed 83 across all filing types
Latest filing 2025-04-24 Report Publication Anno…
Country KY Cayman Islands
Listing HKEX 6086

About Fangzhou Inc.

http://investors.jianke.com

Fangzhou Inc. is a leading online platform specializing in chronic disease management. The company provides comprehensive healthcare technology solutions, operating primarily through segments such as Online Retail Pharmacy Services and Comprehensive Medical Services via its Jianke Platform. Fangzhou focuses on leveraging AI to expand and enhance its chronic disease management offerings, serving a substantial user base reported to exceed 52 million registered users.

Recent filings

Filing Released Lang Actions
Letter to Non-Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
Report Publication Announcement Classification · 85% confidence The document is a corporate notice to non-registered shareholders regarding the new electronic dissemination regime for all future “Corporate Communications” under the Hong Kong Listing Rules. It is not itself an annual or interim report, nor a financial performance release or a governance code, but rather an announcement about how and where reports will be published (i.e. available electronically on the Company and HKExnews websites). This aligns with the definition of an RPA (Report Publication Announcement).
2025-04-24 English
Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings Classification · 85% confidence The document is a notification to registered shareholders about the adoption of electronic dissemination of corporate communications and includes a reply form to collect email addresses. It is not a financial report, earnings release, proxy statement, or dividend notice, nor does it announce a specific report’s publication. It is a general regulatory announcement under the Hong Kong Listing Rules regarding paperless corporate communications. This falls under the fallback category “Regulatory Filings” (Code: RNS).
2025-04-24 English
2024 Annual Report
Annual Report Classification · 100% confidence The document is explicitly titled '2024 Annual Report' and contains comprehensive sections including 'Management Discussion and Analysis', 'Corporate Governance Report', 'Independent Auditor's Report', and full 'Consolidated Financial Statements'. It covers the company's performance for the fiscal year ended December 31, 2024. It is not an announcement of a report, but the report itself. FY 2024
2025-04-23 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2025
Regulatory Filings Classification · 74% confidence The document is a standard Monthly Return (Form FF301) filed with the Hong Kong Stock Exchange under Chapter 19B of the Listing Rules, detailing movements in authorised share capital and issued shares for the month ended 31 March 2025. It is a routine regulatory compliance filing rather than a financial report (10-K, IR) or corporate action announcement (e.g., share issue, delisting). It does not present full financial statements, earnings highlights, management discussion, nor announce a specific corporate event like a share issuance or M&A. Therefore, it falls under the catch-all category for general regulatory filings.
2025-04-07 English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2024
Earnings Release Classification · 85% confidence The document is an announcement of the audited consolidated annual results for the year ended December 31, 2024, published on HKEX. It contains financial highlights, summary financial statements, and Management Discussion & Analysis. This is not the full statutory annual report (10-K) but the initial public release of the year-end results, corresponding to an Earnings Release. FY 2024
2025-03-21 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 85% confidence The document is a board meeting notice announcing the date on which the board will consider and approve the company’s annual results and their publication, as well as dividend matters. It does not contain the results themselves but rather announces the timing of a report approval and publication process. Such notices fall under Report Publication Announcements (RPA).
2025-03-11 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.